Overview Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies Status: Completed Trial end date: 2012-08-01 Target enrollment: Participant gender: Summary The project will improve scientific knowledge regarding a recent law applying potentially to every french driver. It will give for the first time an indication on the impact of alerting treatments on driving risks. It will reinforce the links between different research environments (sleep physiopathology, clinical research, cognitive neurosciences, driver's supervision, virtual reality, pharmacology) among the RESAT network (Réseau Eveil Sommeil Attention Transport). It will stimulate data acquisition in technological research to better understand the difference between real and simulated driving Phase: N/A Details Lead Sponsor: University Hospital, BordeauxTreatments: ArmodafinilModafinil